Cargando…
Corrigendum to “Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment” [Heliyon 8 (9) (2022) e10694]
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647432/ https://www.ncbi.nlm.nih.gov/pubmed/36387508 http://dx.doi.org/10.1016/j.heliyon.2022.e11273 |
_version_ | 1784827381252358144 |
---|---|
author | Ruswanto, Ruswanto Nofianti, Tita Mardianingrum, Richa Kesuma, Dini Siswandono |
author_facet | Ruswanto, Ruswanto Nofianti, Tita Mardianingrum, Richa Kesuma, Dini Siswandono |
author_sort | Ruswanto, Ruswanto |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9647432 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-96474322022-11-15 Corrigendum to “Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment” [Heliyon 8 (9) (2022) e10694] Ruswanto, Ruswanto Nofianti, Tita Mardianingrum, Richa Kesuma, Dini Siswandono Heliyon Corrigendum Elsevier 2022-11-02 /pmc/articles/PMC9647432/ /pubmed/36387508 http://dx.doi.org/10.1016/j.heliyon.2022.e11273 Text en © 2022 The Author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Corrigendum Ruswanto, Ruswanto Nofianti, Tita Mardianingrum, Richa Kesuma, Dini Siswandono Corrigendum to “Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment” [Heliyon 8 (9) (2022) e10694] |
title | Corrigendum to “Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment” [Heliyon 8 (9) (2022) e10694] |
title_full | Corrigendum to “Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment” [Heliyon 8 (9) (2022) e10694] |
title_fullStr | Corrigendum to “Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment” [Heliyon 8 (9) (2022) e10694] |
title_full_unstemmed | Corrigendum to “Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment” [Heliyon 8 (9) (2022) e10694] |
title_short | Corrigendum to “Design, molecular docking, and molecular dynamics of thiourea-iron (III) metal complexes as NUDT5 inhibitors for breast cancer treatment” [Heliyon 8 (9) (2022) e10694] |
title_sort | corrigendum to “design, molecular docking, and molecular dynamics of thiourea-iron (iii) metal complexes as nudt5 inhibitors for breast cancer treatment” [heliyon 8 (9) (2022) e10694] |
topic | Corrigendum |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9647432/ https://www.ncbi.nlm.nih.gov/pubmed/36387508 http://dx.doi.org/10.1016/j.heliyon.2022.e11273 |
work_keys_str_mv | AT ruswantoruswanto corrigendumtodesignmoleculardockingandmoleculardynamicsofthioureaironiiimetalcomplexesasnudt5inhibitorsforbreastcancertreatmentheliyon892022e10694 AT nofiantitita corrigendumtodesignmoleculardockingandmoleculardynamicsofthioureaironiiimetalcomplexesasnudt5inhibitorsforbreastcancertreatmentheliyon892022e10694 AT mardianingrumricha corrigendumtodesignmoleculardockingandmoleculardynamicsofthioureaironiiimetalcomplexesasnudt5inhibitorsforbreastcancertreatmentheliyon892022e10694 AT kesumadini corrigendumtodesignmoleculardockingandmoleculardynamicsofthioureaironiiimetalcomplexesasnudt5inhibitorsforbreastcancertreatmentheliyon892022e10694 AT siswandono corrigendumtodesignmoleculardockingandmoleculardynamicsofthioureaironiiimetalcomplexesasnudt5inhibitorsforbreastcancertreatmentheliyon892022e10694 |